Showing results (561-570 of 639) with videos related to

Sort By:
Pageof 64
Journal of Child and Adolescent Psychopharmacology|March 24, 2006
Fluoxetine 40-60 mg versus fluoxetine 20 mg in the treatment of children and adolescents with a less-than-complete response to nine-week treatment with fluoxetine 10-20 mg: a pilot studyJohn H Heiligenstein, Sharon L Hoog, Karen Dineen Wagner, et al.
Molecular and Cellular Biology|June 2, 2016
ZDHHC3 Tyrosine Phosphorylation Regulates Neural Cell Adhesion Molecule PalmitoylationPatricia Marie-Jeanne Lievens, Tatiana Kuznetsova, Gaga Kochlamazashvili, et al.
European Journal of Pharmacology|December 12, 2024
Cilostazol counteracts mitochondrial dysfunction in hepatic encephalopathy rat model: Insights into the role of cAMP/AMPK/SIRT1/ PINK-1/parkin hub and p-CREB /BDNF/ TrkB neuroprotective trajectoryEnas S Gad, Sara A Aldossary, Mona R El-Ansary, et al.
Membranes|May 28, 2022
All-Solid-State Potentiometric Platforms Modified with a Multi-Walled Carbon Nanotubes for Fluoxetine DeterminationHisham S M Abd-Rabboh, Heba M Hashem, Layla M S Al Shagri, et al.
Voprosy Onkologii|February 28, 2001
[Role of induction chemo- and radiotherapy in the treatment of locally advance breast cancer]E K Voznyĭ, V P Kharchenko, G A Pan'shin, et al.
Molecules (Basel, Switzerland)|June 18, 2020
CuFe2O4/Polyaniline (PANI) Nanocomposite for the Hazard Mercuric Ion Removal: Synthesis, Characterization, and Adsorption Properties StudySaad S M Hassan, Ayman H Kamel, Amr A Hassan, et al.
International Immunopharmacology|May 24, 2024
The potential role of Tirzepatide as adjuvant therapy in countering colistin-induced nephro and neurotoxicity in rats via modulation of PI3K/p-Akt/GSK3-β/NF-kB p65 hub, shielding against oxidative and endoplasmic reticulum stress, and activation of p-CREB/BDNF/TrkB cascadeNoha F Hassan, Diaa Ragab, Shaimaa G Ibrahim, et al.
Polymers|June 18, 2020
Validation of a Novel Potentiometric Method Based on a Polymeric PVC Membrane Sensor Integrated with Tailored Receptors for the Antileukemia Drug CytarabineAyman H Kamel, Abd El-Galil E Amr, Nashwa H Ashmawy, et al.
Terapevticheskii Arkhiv|January 1, 1991
[The characteristics of the clinical course of lymphosarcomas in conformity with the morphological variants of the WHO and Working Formulation classifications]S A Baĭdurin, I B Kaplanskaia, V M Sotnikov, et al.
Voprosy Onkologii|January 1, 1996
[Early peripheral cancer of the lung: long-term results of combined therapy using sparing resection techniques]V P Kharchenko, V D Chkhikvadze, G A Galil-Ogly, et al.
Pageof 64